The 8-hour Buprenorphine Training - PART 1 - 7/8/2023-The Half and Half Course Agenda

The Half and Half Course Agenda

Pdf Summary

This document is summarizing the content of the PCSS Half and Half Course on Office-Based Treatment for Opioid Use Disorders. The course is divided into several sections, each with a designated amount of time.<br /><br />The overview section is 0.5 hours long and covers the treatment of Opioid Use Disorder with Buprenorphine/Naloxone. <br /><br />The patient evaluation section is 0.75 hours long and focuses on the evaluation process for patients with Opioid Use Disorder.<br /><br />Specialty topics are covered for 0.75 hours, discussing specific subjects related to Opioid Use Disorder treatment.<br /><br />There is a case study section that is 0.25 hours long, providing examples of real-life scenarios related to Opioid Use Disorder treatment.<br /><br />The clinical uses of Buprenorphine section is 0.5 hours long, exploring the various clinical applications of this medication.<br /><br />There is another case study section, lasting 0.25 hours, that provides additional examples of case studies related to Opioid Use Disorder treatment.<br /><br />Urine drug testing is covered for 0.5 hours, discussing its role in the treatment of Opioid Use Disorder.<br /><br />There is a brief overview of clinical tools for 0.25 hours, highlighting the various tools available for Opioid Use Disorder treatment.<br /><br />The course includes a 0.25-hour Q&A session for participants to ask questions and gain clarification on the material presented.<br /><br />Throughout the training, there will be 10 interactive polling questions that randomly appear. Answering these questions is not graded, but it is required for participation credit. It helps the presenters gauge the participants' understanding of the material and ensures engagement.

Keywords

PCSS Half and Half Course

Office-Based Treatment

Opioid Use Disorders

Buprenorphine/Naloxone

Patient Evaluation

Specialty Topics

Case Study

Clinical Uses of Buprenorphine

Urine Drug Testing

Clinical Tools